NCT00346970View on ClinicalTrials.gov

The High Density Lipoprotein and Endothelial Function, Niacin and Nitric Oxide Study (The High-Ennd Study)

PHASE4CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

July 31, 2006

Study Completion Date

July 31, 2007

Conditions
Metabolic Syndrome
Interventions
DRUG

Extended-Release Niacin

Extended-Release Niacin tablets week 1-4 500 mg/d week 4-8 1000 mg/d week 9-12 1500 mg/d

DRUG

Placebo

Placebo tablets

Trial Locations (1)

30625

Hannover Medical School, Hanover

All Listed Sponsors
lead

Hannover Medical School

OTHER

NCT00346970 - The High Density Lipoprotein and Endothelial Function, Niacin and Nitric Oxide Study (The High-Ennd Study) | Biotech Hunter | Biotech Hunter